Monitoring glucose levels in infertile women undergoing assisted reproduction
Official title: Glucose Pattern in Infertile Women Receiving Assisted Reproduction: a Prospective Study Using Continuous Glucose Monitoring
Run by Shanghai 6th People's Hospital · NCT06863337 · Data updated 2026-11-12
This study is testing if keeping track of blood sugar levels in women undergoing fertility treatments like IVF can help improve their chances of getting pregnant and having a healthy baby.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Shanghai 6th People's Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | March 26, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | April 30, 2027 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT06863337 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are infertile women aged 18 to 40 who are undergoing their first or second IVF/ICSI cycle.
✕Probably not a fit
Patients with recent infections, glucocorticoid treatment, or specific clinical conditions affecting ART outcomes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to continuously monitor glucose variations in infertile women receiving assisted reproductive technologies (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). By utilizing continuous glucose monitoring (CGM), the research seeks to explore the relationship between glucose fluctuations and ART outcomes, potentially leading to improved clinical pregnancy and live birth rates. The findings may help tailor ART regimens to minimize glucose variation, enhancing individualized patient care. This approach is novel as glucose monitoring is not typically performed during ART cycles.
Why it matters
Potential benefit: If successful, this study could lead to improved pregnancy and live birth rates for women undergoing assisted reproduction.
How similar studies have gone: While this approach of continuous glucose monitoring during ART is novel, similar studies in other contexts have shown promise in optimizing treatment outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Informed consent and voluntary participation in this study; 2. Age ≥ 18 years and ≤40 years old; 3. Infertile patients who will undergo their first or second cycle of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) at the study center; 4. The chosen ovulation promotion regimens is the GnRH antagonist regimen/progesterone-promoting ovulation under hyperprogesterone state (PPOS) regimen. Exclusion Criteria: 1. Recent infections (excluding viral infections of the reproductive system such as HPV); 2. Recent glucocorticoid treatment or chemotherapy; 3. Clinical conditions affecting the outcome of assisted reproduction, including repeated implantation failure, recurrent spontaneous abortion, history of unilateral oophorectomy, uterine malformations, and parental karyotype abnormalities; 4. Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area.
Where it's running
-
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Jian Zhou, Dr.
- Email: zhoujian@sjtu.edu.cn
- Phone: +86 021 24056515
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI into Ultrasound Diagnostics in Reproductive Medicine
Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.
-
Tadalafil to increase uterine lining and improve frozen embryo transfer success
This test sees if adding daily tadalafil to standard estrogen helps women with unexplained infertility using good-quality day‑5 frozen embryos get a thicker uterine lining and better transfer outcomes.
-
FET-LET-2x2: Testing natural vs medicated natural cycles for frozen embryo transfer
This study tests four approaches to preparing the uterus for frozen embryo transfer to see which yields the best pregnancy rate in women undergoing IVF.
-
Integrative care guided by biological aging markers for unexplained female infertility
This trial tests whether measuring telomeres and other biological aging markers can guide a personalized integrative treatment to help women aged 25–42 with persistent unexplained infertility improve their chances of pregnancy.
-
How fitness, heart health, and mental well-being relate to assisted fertility treatments
This study tries to see if physical activity, cardiorespiratory fitness, cardiovascular health, sleep, and stress affect pregnancy chances for women undergoing assisted fertility treatments.
-
How attitudes toward artificial intelligence relate to anxiety and quality of life in women receiving infertility treatment
This study will test whether women's attitudes toward artificial intelligence are linked to their anxiety and quality of life while undergoing infertility treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.